Literature DB >> 15885696

Development of the egg hatch assay for detection of anthelminthic resistance in human hookworms.

Marco Albonico1, Victoria Wright, Mahdi Ramsan, Hamadi J Haji, Martin Taylor, Lorenzo Savioli, Quentin Bickle.   

Abstract

Evidence of development and rapid spread of anthelminthic resistance in veterinary nematodes raises concern that the increasingly frequent treatments used in chemotherapy-based programmes to control human soil-transmitted helminths may select resistant worms. The aim of this study was to adapt, refine, and evaluate the Egg Hatch Assay (EHA) test, which has been used for veterinary nematodes, for field testing of benzimidazole (BZ) susceptibility/resistance in human hookworms. A second objective was to use this EHA to assess whether a population of worms resistant to mebendazole (MBZ) has built up in a sub-population of frequently treated children in Pemba Island. Stools from 470 school children enrolled in the first (Standard 1) and in the fifth (Standard 5) class were examined at baseline and at 21 days after treatment with 500 mg MBZ or placebo tablets. Standard 1 children had never received any MBZ treatment whilst Standard 5 children had received a total of 13 rounds of treatment. The EHA, involving culture of purified eggs with increasing drug concentrations showed that, for thiabendazole (TBZ), the mean ED(50)s (concentrations required to prevent 50% of the viable eggs from hatching) for all children at baseline were 0.079 microg/ml at 48h and 0.120 microg/ml at 72h (P<0.001). For MBZ, the mean ED(50)s for all children at baseline were 0.895 microg/ml at 48h and 1.50 microg/ml at 72h (P<0.001). For TBZ and for MBZ the ED(50) from Standard 1 were similar to those from Standard 5 children both at 48 and at 72h. At the follow-up for TBZ and for MBZ, there was no significant difference between the ED(50) from children who had received MBZ and children treated with placebo. In Pemba, TBZ ED(50) values of children non-exposed (Standard 1) and of children exposed (Standard 5) to MBZ treatment, and data from children treated with MBZ and placebo indicate that a drug-resistant worm population has not built up within treated individuals, and that periodic treatment has not yet selected for widespread BZ resistance, at least at the threshold detectable by the EHA in this study. However, ED(50) values for strains isolated from Mafia island, an area never exposed to BZ treatment were lower than for Pemba, suggesting lowered sensitivity of hookworm eggs recovered from Pembian children towards BZ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885696     DOI: 10.1016/j.ijpara.2005.02.016

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  23 in total

1.  Standardization of the egg hatch test for the detection of benzimidazole resistance in parasitic nematodes.

Authors:  Georg von Samson-Himmelstjerna; Gerald C Coles; Frank Jackson; Christian Bauer; Fred Borgsteede; Veli Y Cirak; Janina Demeler; Alison Donnan; Pierre Dorny; Christian Epe; Achim Harder; Johan Höglund; Ronald Kaminsky; Dominique Kerboeuf; Ulla Küttler; Elias Papadopoulos; Janez Posedi; John Small; Marián Várady; Jozef Vercruysse; Nicole Wirtherle
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

2.  Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure.

Authors:  Debbie Humphries; Emily Mosites; Joseph Otchere; Welbeck Amoani Twum; Lauren Woo; Hinckley Jones-Sanpei; Lisa M Harrison; Richard D Bungiro; Blair Benham-Pyle; Langbong Bimi; Dominic Edoh; Kwabena Bosompem; Michael Wilson; Michael Cappello
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

3.  Molecular and biological diagnostic tests for monitoring benzimidazole resistance in human soil-transmitted helminths.

Authors:  Aïssatou Diawara; Jan M Schwenkenbecher; Ray M Kaplan; Roger K Prichard
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

4.  A microfluidic platform for high-sensitivity, real-time drug screening on C. elegans and parasitic nematodes.

Authors:  John A Carr; Archana Parashar; Richard Gibson; Alan P Robertson; Richard J Martin; Santosh Pandey
Journal:  Lab Chip       Date:  2011-06-06       Impact factor: 6.799

5.  An integrated fiber-optic microfluidic device for detection of muscular force generation of microscopic nematodes.

Authors:  Peng Liu; Depeng Mao; Richard J Martin; Liang Dong
Journal:  Lab Chip       Date:  2012-07-24       Impact factor: 6.799

6.  Hookworm infection among school age children in Kintampo north municipality, Ghana: nutritional risk factors and response to albendazole treatment.

Authors:  Debbie Humphries; Benjamin T Simms; Dylan Davey; Joseph Otchere; Josephine Quagraine; Shawn Terryah; Samuel Newton; Elyssa Berg; Lisa M Harrison; Daniel Boakye; Michael Wilson; Michael Cappello
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

7.  Effect of heterogeneous mixing and vaccination on the dynamics of anthelmintic resistance: a nested model.

Authors:  Lorenzo Sabatelli
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

8.  In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.

Authors:  Rebecca S Treger; Joseph Otchere; Martin F Keil; Josephine E Quagraine; Ganesha Rai; Bryan T Mott; Debbie L Humphries; Michael Wilson; Michael Cappello; Jon J Vermeire
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

9.  Levamisole and ryanodine receptors. II: An electrophysiological study in Ascaris suum.

Authors:  Sreekanth Puttachary; Alan P Robertson; Cheryl L Clark; Richard J Martin
Journal:  Mol Biochem Parasitol       Date:  2010-01-11       Impact factor: 1.759

10.  Application of a Poisson distribution quality control measure to the analysis of two human hookworm drug treatment studies in Ghana.

Authors:  Andrew C Kotze; Robert J Dobson; Debbie Humphries; Michael Wilson; Michael Cappello
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-01-31       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.